Response to: COVID-19 re-infection. Vaccinated individuals as a potential source of transmission.
作者信息
Schiavone Marco, Gasperetti Alessio, Mitacchione Gianfranco, Viecca Maurizio, Forleo Giovanni Battista
机构信息
Cardiology Unit, ASST-Fatebenefratelli Sacco, Luigi Sacco University Hospital, Milan, Italy.
出版信息
Eur J Clin Invest. 2021 Jun;51(6):e13544. doi: 10.1111/eci.13544. Epub 2021 Mar 23.
Abstract
摘要
相似文献
1
Response to: COVID-19 re-infection. Vaccinated individuals as a potential source of transmission.回应：新型冠状病毒肺炎再次感染。接种疫苗的个体作为潜在传播源。
Eur J Clin Invest. 2021 Jun;51(6):e13544. doi: 10.1111/eci.13544. Epub 2021 Mar 23.
2
Protecting healthcare workers: A critical part of the COVID-19 response.保护医护人员：新冠疫情应对的关键部分。
S Afr Med J. 2020 Oct 23;110(12):1154-1155. doi: 10.7196/SAMJ.2020.v110i12.15048.
3
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.BNT162b2疫苗接种者中SARS-CoV-2感染和新冠肺炎的早期感染率降低情况。
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
4
COVID-19 vaccines and decreased transmission of SARS-CoV-2.COVID-19 疫苗与 SARS-CoV-2 传播减少。
Inflammopharmacology. 2021 Oct;29(5):1357-1360. doi: 10.1007/s10787-021-00847-2. Epub 2021 Jul 19.
5
Prevalence of SARS-CoV-2 Infection Among Health Care Workers in a Tertiary Community Hospital.三级社区医院医护人员中 SARS-CoV-2 感染的流行率。
JAMA Intern Med. 2020 Dec 1;180(12):1707-1709. doi: 10.1001/jamainternmed.2020.4214.
6
SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe.津巴布韦前线卫生工作者的 SARS-CoV-2 血清学检测。
PLoS Negl Trop Dis. 2021 Mar 31;15(3):e0009254. doi: 10.1371/journal.pntd.0009254. eCollection 2021 Mar.
7
Interpreting SARS-CoV-2 Diagnostic Tests: Common Questions and Answers.解读 SARS-CoV-2 诊断检测：常见问题与解答。
Am Fam Physician. 2021 Apr 15;103(8):465-472.
8
Infection with SARS-CoV-2 in primary care health care workers assessed by antibody testing.通过抗体检测评估初级保健医护人员中 SARS-CoV-2 的感染情况。
Fam Pract. 2021 Mar 29;38(2):76-79. doi: 10.1093/fampra/cmaa078.
9
Clinical v. laboratory-based screening for COVID-19 in asymptomatic patients requiring acute cardiac care.对需要急性心脏护理的无症状患者进行COVID-19的临床筛查与基于实验室的筛查对比
S Afr Med J. 2020 Sep 29;110(11):13088.
10
Outbreak of Health Care-associated Novel Coronavirus (SARS-coV-2) COVID-19 infections in the Spring of 2020.2020 年春季发生的与医疗保健相关的新型冠状病毒（SARS-CoV-2）COVID-19 感染爆发。
Keio J Med. 2021;70(1):1-6. doi: 10.2302/kjm.kjm-covid19-01.
引用本文的文献
1
Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals.SARS-CoV-2 的未来传播轨迹：人类与动物之间持续的溢出和回溢。
Virus Res. 2023 Apr 15;328:199075. doi: 10.1016/j.virusres.2023.199075. Epub 2023 Feb 28.
2
COVID-19: The Pseudo-Environment and the Need for a Paradigm Change.新冠病毒肺炎：拟态环境与范式转变的必要性
Germs. 2021 Dec 29;11(4):468-477. doi: 10.18683/germs.2021.1283. eCollection 2021 Dec.
3
Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers.医疗机构中涉及接种疫苗的医护人员的 SARS-CoV-2 传播。
Microbiol Spectr. 2022 Feb 23;10(1):e0153221. doi: 10.1128/spectrum.01532-21. Epub 2022 Jan 5.
4
Nature of Acquired Immune Responses, Epitope Specificity and Resultant Protection from SARS-CoV-2.获得性免疫反应的性质、表位特异性以及对严重急性呼吸综合征冠状病毒2的免疫保护
J Pers Med. 2021 Nov 25;11(12):1253. doi: 10.3390/jpm11121253.
5
Analysis of SARS-CoV-2 haplotypes and genomic sequences during 2020 in Victoria, Australia, in the context of putative deficits in innate immune deaminase anti-viral responses.2020 年澳大利亚维多利亚州 SARS-CoV-2 单倍型和基因组序列分析，探讨先天免疫脱氨酶抗病毒反应缺陷的可能性。
Scand J Immunol. 2021 Nov;94(5):e13100. doi: 10.1111/sji.13100. Epub 2021 Sep 30.
6
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.血清阳性医护人员完成 BNT162b2 全程接种后出现有症状的 SARS-CoV-2 感染：来自单一机构的病例系列研究。
Emerg Microbes Infect. 2021 Dec;10(1):1254-1256. doi: 10.1080/22221751.2021.1942230.
本文引用的文献
1
Neutralizing Activity of BNT162b2-Elicited Serum.BNT162b2诱导血清的中和活性
N Engl J Med. 2021 Apr 15;384(15):1466-1468. doi: 10.1056/NEJMc2102017. Epub 2021 Mar 8.
2
COVID-19 re-infection.新冠病毒再次感染
Eur J Clin Invest. 2021 May;51(5):e13537. doi: 10.1111/eci.13537. Epub 2021 Mar 17.
3
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
4
COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission.COVID-19 疫苗可能无法预防鼻腔 SARS-CoV-2 感染和无症状传播。
Otolaryngol Head Neck Surg. 2021 Feb;164(2):305-307. doi: 10.1177/0194599820982633. Epub 2020 Dec 15.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.评估 mRNA-1273 疫苗对 SARS-CoV-2 在非人类灵长类动物中的效果。
N Engl J Med. 2020 Oct 15;383(16):1544-1555. doi: 10.1056/NEJMoa2024671. Epub 2020 Jul 28.
7
: are we taking care of healthcare workers in the Italian COVID-19 outbreak?在意大利新冠疫情爆发期间，我们是否照顾好了医护人员？
J Hosp Infect. 2020 Jul;105(3):580-581. doi: 10.1016/j.jhin.2020.04.045. Epub 2020 May 7.
8
Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines.用活疫苗或灭活脊髓灰质炎疫苗免疫后对脊髓灰质炎病毒颗粒多肽的免疫反应特征。
J Infect Dis. 1988 Jul;158(1):160-5. doi: 10.1093/infdis/158.1.160.
Zotero 插件